Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Demographic and clinical data at the time of enrolment for Brazilian subjects with symptomatic V30M ATTRv-PN were extracted from the ongoing, multinational, longitudinal, observational Transthyretin Amyloidosis Outcomes Survey (THAOS; cut-off date: January 30, 2017). 31163298

2019

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families. 30811423

2019

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Our case suggests that serial native T1 and extracellular volume may be novel non-invasive imaging methods to monitor the treatment response to TTR stabilizers in cardiac amyloidosis and also that tafamidis may be effective in suppressing cardiac progression in TTR amyloid cardiomyopathy with Val30Met mutation. 30478886

2019

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease. 27992035

2017

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE There have been a few encouraging studies on Tafamidis efficacy in early-onset inherited transthyretin amyloidosis (ATTR) due to Val30Met mutation. 26984605

2016

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE The overall 5-year survival rate is approximately 100% for V30M patients and 59% for non-ATTR V30M patients. 25482846

2015

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Our findings indicate that CNS clinical involvement occurs in ATTR-V30M patients regardless of LT. Longer disease duration after LT can provide the necessary time for transthyretin amyloidosis to progress until it becomes clinically relevant. 25091367

2015

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. 25743445

2015

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis. 24101373

2013

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. 23185504

2012

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE The V30M to wild type TTR ratio in plasma is the same for all ATTR patients studied, showing no variation with disease clinical progression. 22080762

2011

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Our study included 8 cases of acquired monoclonal immunoglobulin light chain amyloidosis, 11 cases of transthyretin amyloidosis (3 with the Val30Met mutation, 2 with the Val32Ala mutation, 2 with the Thr60Ala mutation, 1 with the Ala109Ser mutation, 1 with the Phe64Leu mutation, 1 with the Ala97Ser mutation, and 1 not sequenced), and 2 cases of gelsolin amyloidosis (1 with the Asp187Asn mutation and 1 not sequenced). 20937937

2011

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Three of the 46 cases with HCM carried the Val30Met mutation, and were considered likely to have cardiac amyloidosis, like the index case. 16115295

2005

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report. 15523922

2004

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE It is also noteworthy that serious cardiac amyloidosis is commonly seen in patients with FAP of the non-Val30Met TTR type. 11940682

2002

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE The method was successfully tested using serum from ATTR patients with known variants (Val30-->Met and Val122-->Ile). 9949732

1999